Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion

INTRODUCTION: Levodopa/carbidopa intestinal gel (LCIG) is an effective treatment in patients with advanced Parkinson’s disease (PD) with consolidated evidence of clinical efficacy. However, only few studies have assessed long-term safety, causes of discontinuation, mortality, and relative predictors...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrì, Federica, Russo, Francesco Paolo, Carrer, Tommaso, Weis, Luca, Pistonesi, Francesca, Mainardi, Michele, Sandre, Michele, Savarino, Edoardo, Farinati, Fabio, Del Sorbo, Francesca, Soliveri, Paola, Calandrella, Daniela, Biundo, Roberta, Carecchio, Miryam, Zecchinelli, Anna Lena, Pezzoli, Gianni, Antonini, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309989/
https://www.ncbi.nlm.nih.gov/pubmed/35876875
http://dx.doi.org/10.1007/s00415-022-11269-7

Ejemplares similares

Ejemplares similares